The doctor-turned-investor is the majority owner of Bloomfield Hills-based holding company Shamekh IV Solutions — funded by his family’s Wixom-based medical distribution conglomerate J&B Medical — which was among a handful of companies announced as part of a mutual investment agreement announced by President Donald Trump this week. Shamekh IV plans to invest $5.8 billion in the global production of intravenous fluids and genomic products, starting in Saudi Arabia under the subsidiary Shamekh Life Sciences.
https://www.crainsdetroit.com/health...etroit-projectBut just like Shaya, Shamekh will return home with a planned $500 million investment in the city of Detroit to build a similar plant as part of the larger project. The plan calls for a five-acre property with a 125,000-square-foot building, Shaya told Crain’s Wednesday, only an hour after arriving back from Ryad. The plan includes housing for employees and a workforce development program.
“We want to reimagine the supply chain,” Shaya said. “I’m from Detroit, so it makes sense to open something here. And we’ve seen just how fragile the supply chain is.”
Bookmarks